1. Home
  2. NXL vs RVP Comparison

NXL vs RVP Comparison

Compare NXL & RVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXL
  • RVP
  • Stock Information
  • Founded
  • NXL 2010
  • RVP 1994
  • Country
  • NXL United States
  • RVP United States
  • Employees
  • NXL N/A
  • RVP N/A
  • Industry
  • NXL Medical Specialities
  • RVP Medical/Dental Instruments
  • Sector
  • NXL Health Care
  • RVP Health Care
  • Exchange
  • NXL Nasdaq
  • RVP Nasdaq
  • Market Cap
  • NXL 21.0M
  • RVP 19.8M
  • IPO Year
  • NXL 2022
  • RVP 2001
  • Fundamental
  • Price
  • NXL $1.00
  • RVP $0.66
  • Analyst Decision
  • NXL Strong Buy
  • RVP
  • Analyst Count
  • NXL 1
  • RVP 0
  • Target Price
  • NXL $5.00
  • RVP N/A
  • AVG Volume (30 Days)
  • NXL 87.1K
  • RVP 32.5K
  • Earning Date
  • NXL 08-07-2025
  • RVP 08-13-2025
  • Dividend Yield
  • NXL N/A
  • RVP N/A
  • EPS Growth
  • NXL N/A
  • RVP N/A
  • EPS
  • NXL N/A
  • RVP N/A
  • Revenue
  • NXL $131,065.00
  • RVP $33,745,343.00
  • Revenue This Year
  • NXL $79.59
  • RVP N/A
  • Revenue Next Year
  • NXL $334.65
  • RVP N/A
  • P/E Ratio
  • NXL N/A
  • RVP N/A
  • Revenue Growth
  • NXL N/A
  • RVP N/A
  • 52 Week Low
  • NXL $0.59
  • RVP $0.56
  • 52 Week High
  • NXL $4.49
  • RVP $1.21
  • Technical
  • Relative Strength Index (RSI)
  • NXL 31.62
  • RVP 46.38
  • Support Level
  • NXL $0.89
  • RVP $0.63
  • Resistance Level
  • NXL $1.05
  • RVP $0.68
  • Average True Range (ATR)
  • NXL 0.09
  • RVP 0.04
  • MACD
  • NXL -0.00
  • RVP 0.00
  • Stochastic Oscillator
  • NXL 21.87
  • RVP 33.33

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

About RVP Retractable Technologies Inc.

Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company's other products.

Share on Social Networks: